Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnotec is a leading biotechnology company based in Santiago, Chile, specializing in advanced molecular diagnostic solutions for the aquaculture, agriculture, and human health sectors. Founded in 1997, the company has established itself as a critical partner for the global salmon industry, providing high-precision PCR-based assays for the detection of pathogens such as the ISA virus and Piscirickettsia salmonis. Through a strategic alliance with Phibro Animal Health, Diagnotec has expanded its reach, offering comprehensive diagnostic services and environmental monitoring to international markets. The company also operates a human health division focused on infectious disease testing, oncology biomarkers, and genetic screening, supported by state-of-the-art laboratory infrastructure. Diagnotec's focus on innovation and regional expertise makes it a key player in the Latin American biotech landscape, particularly in the development of tailored diagnostic tools for emerging biological threats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIAGNOTEC.